UNSPSC 51283501: Cloxacillin

This classification denotes a penicillin antibiotic with the molecular formula C19H18ClN3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O6X5QGC2VB, chemically known as 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as cloxacillin, which bears US NIH Compound Identifier 6098. European Medicines Agency schedules Cloxacillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06780MIG.

UNSPSC 51283501 Cloxacillin is a Commodity code that nominally addresses a specific antibiotic pharmaceutical, yet the recent state and local opportunities tagged to it span a broader pharmaceutical and medical supply procurement landscape—including naloxone, first aid supplies for emergency response, generic multi-source pharmaceuticals, and direct-to-manufacturer prescription programs. The mismatch between the narrow code name and the actual work being solicited suggests the code functions as a catch-all for pharma-related purchases or is applied inconsistently across jurisdictions. State and local buyers under this code include county health departments (Seminole County, Florida), city fire and rescue services (Tampa), state health and human services agencies (Texas HHS Commission), and cooperative purchasing alliances serving multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance). The scope of work spans emergency-response pharmaceuticals and supplies, fire department medical consumables, generic drug procurement for government employee health programs, and exploratory direct-to-manufacturer contracting models intended to bypass traditional pharmacy benefit managers.

Recent activity concentrates in Florida, Texas, and Minnesota, with multi-state reach through cooperative purchasing. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (response deadline July 26, 2023), the City of Tampa's sheltered-market IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a response deadline of March 13, 2026, the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products available to participating state and local facilities nationwide (response deadline March 26, 2026), and the Texas HHS Commission's Request for Information on direct-to-manufacturer prescription programs (response deadline April 3, 2026). The Tampa opportunity includes a 5 percent bid discount for certified Small Local Business Enterprises and requires compliance with ADA and Section 508 accessibility standards; the MMCAP RFP mandates compliance with cGMP, DSCSA, and FDA requirements, with performance penalties ranging from $200 to $1,500 per violation.